MAR 05, 2017 08:19 AM PST

WHO Alerts the Globe to the 12 Deadliest Microbes

WRITTEN BY: Carmen Leitch
3 26 1653

Alarm bells have been ringing all over the world about drug-resistant superbugs, which are expected to pose a huge threat to human health in the coming decades. Years of overuse, misuse, and poor prescribing and purchasing habits has created a serious problem whereby humanity can no longer rely on the old standards that have been used to effectively treat bacterial infections for decades. The United Nations has identified the threat, now the World Health Organization has produced a list of twelve microbes that are seen as major priorities for antibiotic development.

The WHO aims to promote research and development by publishing this list, and they have categorized the bacteria by how urgent the threat has been perceived to be - critical, high, and medium priority. 

The biggest problem is seen as the one that affects people already dealing with health issues - those infections that are primarily found in hospital, clinic and nursing home settings. In this group are Acinetobacter, Pseudomonas and the family of Enterobacteriaceae which includes Klebsiella, Proteus and the commonly known E. coli. Those bacteria often cause pneumonia and infections of the blood. Bacteria that have become resistant to virtually all antibiotic treatments are in this group. Carbapenems are seen as a last-resort treatment for various bacterial infections that are impervious to typical treatments, and some bacterial strains have gained resistance to those drugs (usually by gaining a piece of genetic material). The next categories include bacteria that are still very dangerous, resulting in illnesses like gonorrhoea and food-borne illness.

"This list is a new tool to ensure R&D responds to urgent public health needs," explained Dr Marie-Paule Kieny, WHO's Assistant Director-General for Health Systems and Innovation. "Antibiotic resistance is growing, and we are fast running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time."

There is global attention on this problem, which is planned to be discussed at a meeting of health experts in Berlin. "We need effective antibiotics for our health systems. We have to take joint action today for a healthier tomorrow. Therefore, we will discuss and bring the attention of the G20 to the fight against antimicrobial resistance. WHO’s first global priority pathogen list is an important new tool to secure and guide research and development related to new antibiotics," commented Mr Hermann Gröhe, the Federal Minister of Health.

The list was created by scientists at the Division of Infectious Diseases at the University of Tübingen, Germany, considering characteristics like how deadly resulting infections are, how treatable they are, how easily they spread, how preventable they are, etc. The list was then reviewed by international experts.

"New antibiotics targeting this priority list of pathogens will help to reduce deaths due to resistant infections around the world," said one researchers that helped to curate the list, Professor Evelina Tacconelli, who is Head of the Division of Infectious Diseases at the University of Tübingen. "Waiting any longer will cause further public health problems and dramatically impact on patient care."

 

Source: WHO

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 08, 2018
Genetics & Genomics
MAY 08, 2018
A Genetic Assessment of a Drug-resistant Pathogen
Drug resistance is a growing threat to public health and is responsible for the death of around 23,000 people every year in the US alone.
JUN 22, 2018
Microbiology
JUN 22, 2018
Antiviral Compound Found in the Human Body
The human body can make a compound with a special power to fight viruses - an enzyme called viperin.
JUN 30, 2018
Videos
JUN 30, 2018
First US Case of Bubonic Plague in 26 Years is Reported
It's not known exactly where the patient contracted the disease, but it was either Idaho or Oregon.
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Increased Dose of Drug 'Rifampin' Effective in Eliminating Tuberculosis Bacterium
According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when a
JUL 23, 2018
Genetics & Genomics
JUL 23, 2018
Developing Self-fertilizing Plants
Plants of the future may not need to be fertilized; they might create their own nutrients. That could be a huge relief for the planet.
AUG 03, 2018
Microbiology
AUG 03, 2018
Dog Lick Leads to Limb Amputation
The CDC says don't give your dog up; this is thought to be a very rare case.
Loading Comments...